Fig 1.
Joinpoint regression analysis figures for global prevalence, incidence, and DALYs of CRDs, COPD, Asthma, and ILD & PS, along with Age-Gender Pyramids for Their Incidence.
Fig 2.
Trends in the prevalence burden of CRDs with changes in SDI at the global level, 5 SDI regions, and 21 GBD regions.
Fig 3.
Trends in the incidence of CRDs, COPD, asthma, and ILD & PS over the past 30 Years in 204 countries globally; EAPC(1990-2021); A: CRDs EAPC for incidence rate; B: COPD EAPC for incidence rate; C: Asthma EAPC for incidence rate; D: ILD & PS EAPC for incidence rate; The mapping was done using publicly available R packages, based on publicly available world map data from the Natural Earth data project (https://www.rdocumentation.org/packages/maps/versions/3.4.2).
Fig 4.
APC model analysis figures for the incidence of CRDs, COPD, Asthma, and ILD & PS at the global level; A: Age effect figures for the incidence of CRDs, COPD, Asthma, and ILD & PS at the global level; B: Period effect figures for the incidence of CRDs, COPD, Asthma, and ILD & PS at the global level; C: Cohort effect figures for the incidence of CRDs, COPD, Asthma, and ILD & PS at the global level.
Fig 5.
Prevalence and incidence of CRDs, COPD, Asthma, and ILD & PS at the Global Level, 5 SDI regions, and 21 GBD regions; EAPC: 2019-2021.
Fig 6.
Global cross-country analysis of health inequalities in the prevalence of CRDs, COPD, Asthma, and ILD & PS.
Fig 7.
Projected trends in the global prevalence and incidence burden of CRDs Over the next 20 years in terms of cases and rate.
Fig 8.
BAPC projected trends in the prevalence and incidence burden of CRDs, COPD, Asthma, and ILD & PS over the next 10 years at the global level.
Table 1.
Comprehensive overview of the prevalence, incidence, mortality, and DALYs of CRDs at the global level and in 5 SDI regions (EAPC, Time Points: 1990, 2019, 2021).
Fig 9.
Risk factors associated with the DALYs Rate of CRDs, COPD, and Asthma at the global level, 5 SDI regions, and 21 GBD regions.